Regional Committee for Europe Sixtieth session...Regional Committee for Europe . Sixtieth session ....

Regional Committee for Europe Sixtieth session

Moscow, 13–16 September 2010

Provisional agenda item 7(e) EUR/RC60/7 Rev.1 Add.3

1 September 2010 102187

ORIGINAL: ENGLISH

Membership of WHO bodies and committees

World Health Assembly resolution 63.28 recommended the establishment of the Consultative Expert Working Group (CEWG) on Research and Development: Financing and Coordination (WHA 63.28 is attached as Annex 1). By note verbale of 30 June 2010, the Director-General invited Member States to submit nominations to the CEWG to the respective Regional Director. The deadline for receipt of nominations was subsequently extended to 30 August 2010, as advised in the Regional Director’s letter of 23 August 2010. This document contains the curricula vitae of candidates nominated by the Governments of Armenia, Denmark, Finland, France, Germany, Israel, Montenegro, Norway, Portugal, Republic of Moldova, Spain and Switzerland. Additional material, where supplied by candidates, is available from the Secretariat. The Regional Committee is therefore requested to consider the nominations received and make a recommendation of those candidates to be forwarded to the Director General. As a first step, all the nominations recommended by the Regional Committee will be included in a global roster. Drawing on this roster, the Director-General will then propose the composition of the CEWG to the 128th session of the Executive Board in January 2011. Following approval by the Executive Board of the members of the CEWG, the Director-General will propose the holding of the first meeting of the CEWG, which is expected to be held in the first quarter of 2011.

WORLD HEALTH OR GANIZAT ION • R EGIONAL OFF ICE FOR EUROPE Scherfigsvej 8, DK-2100 Copenhagen Ø, Denmark Telephone: +45 39 17 17 17 Fax: +45 39 17 18 18

Electronic mail: [email protected] World Wide Web address: http://www.euro.who.int

EUR/RC60/7 Rev.1 Add.3 page 3

Terms of reference of the CEWG

The CEWG will:

(a) take forward the work of the Expert Working Group which submitted its final report to the WHA in 2009;

(b) undertake further analysis of the proposals in the Expert Working Group’s report, and in particular: (i) examine the practical details of the four innovative sources of financing proposed in the report of the Expert Working Group; (ii) review the five promising proposals identified n the report of the Expert Working Group; and (iii) further explore the six proposals that did not meet the criteria applied by the Expert Working Group;

(c) consider additional submissions and proposals from Member States, including those arising out of any regional and subregional consultations, and from other stakeholders;

(d) in carrying out the actions in subparagraphs (b) and (c), examine the appropriateness of various research and development financing approaches and the feasibility of implementing these approaches in each of the six WHO regions, with subregional analysis, as appropriate;

(e) observe scientific integrity and avoid conflicts of interest in its work;.

Composition

The recommendation to the Executive Board on the composition of the CEWG will be based on regional representation according to the composition of the Executive Board, gender balance and diversity of experience.

Nominations

The following nominations were received at the Regional Office by 30 August 2010 and curricula vitae in standard format are contained in the following pages:

Armenia (Dr Ara Ter-Grigoryan) Denmark (Professor Flemming Konradsen) Finland (Dr Meri Tuulikki Koivusalo) France (Dr Jean Edmond Deregnaucourt) Germany (Ms Ursula Schaefer-Preuss) Israel (Dr Benny Leshem) Montenegro (Ms Ruzica Milutinovic) Norway (Dr John-Arne Røttingen) Portugal (Dr Isabel Carvalho-Oliveira) Republic of Moldova (Professor Aurel Grossu) Spain (Dr Anto Boqué)

(Dr Rodriguez Artalejo) Switzerland (Dr Paul Linus Herrling).

EUR/RC60/7 Rev.1 Add.3 page 4 NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING GROUP

ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION

CURRICULUM VITAE Member State making nomination: ARMENIA

Family name TER-GRIGORYAN First/Other names Ara Male/Female Male Date of birth 6 March 1953

Contact address (include mobile number and e-mail):

G. Hoysepyan St. 10,. Yerevan. 0047, Republic of Armenia. State Health (Financing) Agency of the Ministry of Health of the Republic of Armenia. Mobile: 0037499007006; e-mail: [email protected]

Field(s) of expertise:

Health policy, health planning and administration, health financing and management, health reform

Professional education: relevant important qualifications Year

Yerevan State Medical University, Internal Medicine Department PhD (Medical Sciences) Moscow First Medical Academy named after E.M. Sechenov.

Moscow, Russian Federation Postgraduate courses, study tours, scientific research seminars on health policy, health

planning and administration. health financing and management. health care system reforms

Professional career: list current post first, followed by up to four most important positions held Year (start/end)

Head of the State Health (Financing) Agency of the Ministry of Health Member of the National Health Accounts Steering Committee appointed by the Prime Minister,

Coordinator of the Working Group on National Health Accounts National Counterpart on Health Financing component in Biennial Collaborative Agreements(BCA) Member of the Specialized Scientific Council on Public health and health organization of the Supreme

Certification Commission of Armenia

Contributions: Significant contribution to the field of research and development: financing and coordination

Research on principles and mechanisms of health care system organization, administration andfinancing and their integration under market conditions.

Research and implementation related to the Basic Benefits Package design and implementation,resource allocation, new provider payment mechanisms in health system (case-based and per capita financing, global budget in contracting, performance-based financing), health service purchasing and contracting. restructuring of health-care delivery systems and health-care systems.

Research on national health accounts and sub-accounts in Armenia. Research on introducing co-payments in Armenia

Publications: List five significant publications relevant to biomedical research and development: financing and coordination

Role of health economics in the financial-economic management of the health care system National Health Accounts (NHA) to Improve Health Policy in Armenia Models and Mechanisms of Economic Relations between the Customer and Provider of Medical CareApplication of modem models of health care organization and financing in the Republic of Armenia The role of independent financing body in the management of financial flows in health care system


NOMINATION FOR MEMBERSHIP OF THE CONSULTATIVE EXPERT WORKING GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION

CURRICULUM VITAE Member State making nomination: DENMARK

Family name KONRADSEN First/Other names Flemming Male/Female Male Date of birth 5 February 1965


School of Global Health, Øster Farimagsgade 5, bygning 9, PO. BOX 2099, 1014 Copenhagen K Telephone +45 60 10 16 61 E-mail: [email protected]


Public health and environmental health in low-income countries


BSc; Cand. Scient.; PhD with a focus on environmental health and public health in low-income countries


Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark

Professor, International Environmental Health focusing on research and training on vectorborne diseases, water supply and sanitation, toxicology and health and climate change inlow and middle income countries.

Jan 2008 topresent

Rollings School of Public Health, Emory University, Atlanta, USA Fellow providing input to the curricula in environmental health, research project

management and research methods through supervision of students and courses. Facilitates links between University of Copenhagen and Emory University in the field of global health

Aug 2007 topresent

Department of International Health, Immunology and Microbiology, University of Copenhagen, Denmark

Deputy Head of Department and Study Director for the Masters of International Health programme. Member, Scientific Advisory Board, Integrated Programme for Malaria Control in sub-Saharan Africa

Jan 2007 topresent

Consultative Group for International Agricultural Research/International Water Management Institute, Sri Lanka

Senior international health expert on secondment from the Danish government to assist with the analysis, project completion and handing over of environmental health research projects in Sri Lanka, Vietnam, India and Ghana. Due to the Tsunami in Asia, time was also allocated for relief efforts in December 2005

Jun 2004–Jul 2005

EUR/RC60/7 Rev.1 Add.3 page 6 DENMARK – Konradsen cont’d Institute of Public Health, University of Copenhagen, Denmark Associate Professor; from January 2006 Head, Section of International Health; from 2002

member of the governing board for the Institute of Public Health. Research focuses on environmental health issues of relevance to low- and middle-income countries. In addition to research tasks, responsible for development of the general curriculum in International Health and related courses for the students of Public Health Sciences. Further responsibility for teaching and planning of the modules related to water supply and sanitation, disease vector control and exercises in epidemiology at the Masters of International Health Programme. Thesis supervisor of students in Medicine, Public HealtSciences and Masters of International Health. Provided teaching input to courses in relation to water supply, sanitation, hygiene promotion and malaria control at a number oDanish and European universities.

Oct 2000–Dec 2007


Substantial research in public health, especially in the areas of environmental health; water supply andsanitation; hygiene promotion; acute pesticide poisoning; control of vector-borne diseases; agriculture and human health; health and water resources management, and malaria.

Contribution to establishment of School of Global Health in Denmark


Pesticide self-poisoning: thinking outside the box. Konradsen et al., Lancet, 2007 Engineering and malaria control: learning from the past 100 years. Konradsen et al., Acta Tropica,

2004 Reducing acute poisoning in developing countries – options for restricting the availability of pesticides.

Konradsen et al., Toxicology, 2003 Cost of malaria control in Sri Lanka. Konradsen et al., WHO Bulletin, 1999 Measuring the economic cost of malaria to households in Sri Lanka. Konradsen et al., American

Journal of Tropical Medicine and Hygiene, 1997 A full list of publications can be found by following this link:



CURRICULUM VITAE

Member State making nomination: FINLAND Family name KOIVUSALO First/Other names Meri Tuulikki Male/Female Female Date of birth 5 January 1964


National Institute for Health and Welfare, PO Box 30, 00271 Helsinki, Finland Phone: +358405091565; email: [email protected] or [email protected]


International health policy, health systems organization and financing, global health


MD (University of Helsinki), MSc (London School of Hygiene and Tropical Medicine), PhD (University of Helsinki)


Senior Researcher, National Institute for Health and Welfare Advisory work for Ministry of Social Affairs and Health and Ministry of Foreign Affairs on health, health

policy and global health issues Member of WHO scientific resource group on trade and health One of three editors of the journal Global Social Policy 2005–2010 One of six expert evaluators of the European Commission’s International Cooperation with Developing

Countries (INCO-DC) programme on health systems


Advisor to and member of the Finnish delegation to Intergovernmental Working Group (IGWG) negotiationsin 2006 and responsible for making the initial European Union background paper on issues and stands

Expert in negotiations concerning the IGWG – Global Plan and Strategy for Action on Public Health,Innovation and Intellectual Property Rights

Academic contribution as part of an international project funded by the United Kingdom Economic andSocial Research Council (ESRC) on nongovernmental action to improve the access of the poor to good-quality low-cost drugs, working papers currently available at http://www.open.ac.uk/ikd/projects_lowcostdrugs.shtml


Koivusalo M, Ollila E. Making a healthy world. Agencies, actors and policies in international health.: London, Zed Books, 1997.

Mackintosh M, Koivusalo M (eds). Globalization and commercialization in health: global and local trends and responses. Basingstoke, Palgrave, 2005.

Koivusalo M. Trade and health – the ethics of global rights, regulation and redistribution. In: Benatar S,Brock G (eds). Global health ethics. Cambridge, Cambridge University Press (in press).

Koivusalo M et al. Globalization and policy space for health and social determinants of health. In: Labonte Ret al. (eds). Globalization and health: Pathways, evidence and policy. New York/London, Routledge, 2009.

Koivusalo M, Mackintosh M. Commercial influence and global nongovernmental public action in health and pharmaceutical policies. International Journal of Health Services (in press)



CURRICULUM VITAE Member State making nomination: FRANCE

Family name DEREGNAUCOURT First/Other names Jean, Edmond Male/Female Male Date of birth 22 May 1948


Institut Pasteu 28 rue du Docteur Roux - 75724 Paris Cedex 15 – France Tel.: 33 (0) 1.40.61.32.43; Fax: 33 (0) 1.40.61.36.96; mobile: 33 (0) 6.29.37.31.97 E-mail : [email protected]


Research Development. Medicine registration. Support operations for innovation in biotechnology and health. Wide experience of international collaboration in English


Doctor of veterinary medicine Certificate of Higher Studies in Pharmacolgy Post doctoral, University of California at Los Angeles (UCLA)


Directory of Research applications and Industiral Relations, Institut Pasteur 2010Delegate General, Medice Biocluster, Paris Région 2009-2010Director of Biotechnogies, Ministry of Higher Education and Research 2003-2006Chairman and Director of Research and Development, Pierre Fabre Laboratories 1998-2003Vice-Chairman of International Chemical and Pharmaceutical Development, Rhône

Poulenc Rorer (Aventis) 1994-1998


Significant contributions to three activities relating to financing and coordination of research and development: - initiated appeal for the National Research Agency project on the emergence and development ofhigh-potential projects;- was a major contributor to the formation of the European Biotechnologies networkEUROTRANSBIO - was a partner in the Advanced Bioclusters for Europe network.

Vice-Chairman of the intergovernmental Franco-Chinese Committee on the development of traditional Chinese medicine




CURRICULUM VITAE Member State making nomination: GERMANY

Family name SCHAEFER-PREUSS First/Other names Ursula Male/Female Female Date of birth


6 ADB Avenue, Mandaluyong City 1550, Philippines Tel: +63-2 632 5006; e-mail: [email protected]


Economics, sociology, development policy


Postgraduate studies in political science, economics and sociology, major in developmentpolicy


Vice President, Asian Development Bank (ADB) 2006–presentDirector General, Federal Ministry for Economics Cooperation and Development

(Bundesministerium für Wirtschaftliche Zusammenarbeit (BMZ)) 2000–2006

Chief of Cabinet of the Federal Ministry for Economics Cooperation and Development (BMZ)

1998–2000

Head of Division, Latin America (East), Mexico and regional development policy in Latin America (BM2)

1995–1998


Responsible for ADB's Regional and Sustainable Development Department and Economics andResearch. Member of the advisory board of various research-oriented development institutes. Member of the Genman Society for Foreign Policy. Author of publications on development issues. Former member of the Expert Working Group.




CURRICULUM VITAE Member State making nomination: ISRAEL

Family name LESHEM First/Other names Benny Male/Female Male Date of birth 17 August 1946


Director, Medical Research Administration, The Chief Scientist Office Ministry of Health, 2, Ben-Tabai St., Jerusalem 91010, Israel Tel: +972-2-568-1208; Fax: +972-2-672-5833; Mobile: +972-50-624-2187 E-mail: [email protected]


Immunology; Research Administration


Ph.D. in Immunology 1979Higher courses in executive administration


Director, Medical Research Administration, the Chief Scientist Office, Israeli Ministry of Health

1999-present

Board member in European Research Area Networks (ERA-Nets): CoCanCPG, ERA-IB, ERA-Age, ERA-Age 2, ERA-Neuron, ERA-PathoGenoMics (Chairperson 2009), EuroNanoMed (Vice-Chairperson 2009 to date)

2004-present

Researcher, Assistant Professor, Lautenberg Center for General and Tumor Immunology, Hebrew University–Hadassah Medical School, Jerusalem, Israel

1981-1999


Set-up of an on-line research application system; Set-up of peer review panels for applications; Funding of medical research projects; Set-up of coordinated activities on "Science to Society"; Set-up of research relations with member countries of the European Union (EU) and Canada; Coordination of multinational joint calls for research applications.


Bronstein-Sitton N et al. Sustained exposure to bacterial antigen induces interferon-gamma-dependent T cell receptor zeta down-regulation and impaired T cell function. Nat Immunol. 2003 Oct;4(10):957-64.

Fervers B et al. CoCanCPG. Coordination of cancer clinical practice in Europe. Tumori, 2008, 94(2): 154-159.

Golenser J et al. Iron chelators: correlation between effects on Plasmodium spp. and immune functions., J Parasitol. 2006 Feb;92(1):170-7.

Leshem B, Rager B. Chief Scientist Research Grants, Israeli Medical Encyclopedia, 2007, 9: 2132


ISRAEL – Leshem cont’d Leshem B et al. Correlation between enhancement of graft-versus-leukemia effects following

allogeneic bone marrow transplantation by rIL-2 and increased frequency of cytotoxic T-lymphocyte precursors in murine myeloid leukemia. Cytokines Cell Mol Ther. 2000 Sep;6(3):141-7.

Leshem B et al. Induction of preferential cytotoxicity against allogeneic mouse lymphoma cells: in vitro and in vivo studies. Cancer Immunol Immunother. 1999 Jul;48(4):179-88.

Rager B, Leshem B. Chief Scientist at the Israeli Ministry of health, Israeli Medical Encyclopedia, 2007, 9: 2126

Rager B et al. Medical research in Israel: future challenges. Isr Med Assoc J. 2000 Jul;2 Suppl:2-4.



CURRICULUM VITAE Member State making nomination: MONTENEGRO

Family name MILUTINOVIC First/Other names Ruzica Male/Female Female Date of birth 16 October 1974


+382 67514316 [email protected]


Financing and coordination


Master’s Degree in Actuarial Science 2007Podgorica School of Economics, University of Montenegro – Bachelor’s Degree, Major in

Management 2000


Montenegro National Health Insurance Fund. Head of the department for monitoring the collection of compulsory health insurance contributions and making national health insurance accounts

Nov 2006 to present

Montenegro National Health Insurance Fund. Head of the department for maintaining records of insured beneficiaries

Jan 2003–Nov 2006


World Bank – Local consultant under technical assistance in the design and production of nationalhealth accounts

Team member for the Ministry of Finance project on “Unified registration and collection of taxes and contributions”


Kašćelan V, Milutinović R. Health insurance market in Montenegro. Accounting and Audit, 3 (2008). Milutinović R. Analysis of material and financial expenditure on medications that are prescribed and

issued at the expense of the Health Insurance Fund for the period 2006-2008 (2008) Milutinović R. Analysis of tender prices of medications for the period 2005-2008 (2008) Milutinović R. Analysis of the consumption of medications and medical devices issued at the expense

of the National Health Insurance Fund in pharmacy institutions of Montenegro in 2007 (2008) Milutinović R. Analysis of the consumption of medications and medical devices issued at the expense

of the National Health Insurance Fund in pharmacy institutions of Montenegro in 2006 (2007)



CURRICULUM VITAE Member State making nomination: NORWAY

Family name RØTTINGEN First/Other names John-Arne Male/Female Male Date of birth 27 March 1969


Norwegian Knowledge Centre for the Health Services PO Box 7004 St Olavs plass, N-0130 Oslo Norway Mobile: +4795980589; e-mail: [email protected]


Biomedicine, Infectious disease epidemiology, health services research, health technology assessment, research policy


MSc (Distinction) in Epidemiology, Evolution and Control of Infectious Disease, Wellcome Trust Centre for the Epidemiology of Infectious Disease, Department of Zoology, University of Oxford

2000

PhD; Faculty of Medicine and The Biotechnology Centre of Oslo, University of Oslo 1999Authorized clinical medical doctor in Norway 1998MD, Faculty of Medicine, University of Oslo 1996


Adjunct Professor in Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, Faculty of Medicine, University of Oslo

Jan 2010–present

Chief executive/Director-General, Norwegian Knowledge Centre for the Health Services

Feb 2004–present

Associate Professor, Head of Medical Research Curriculum, thematic leader, Centre for the Prevention of Global Infections, Faculty of Medicine, University of Oslo

Jul 2002–Jan 2004

Research coordinator, Department of Infectious Disease Epidemiology, Division for Infectious Disease Control, Norwegian Institute of Public Health

Mar 2002–Jan 2004


Board member and now Chair of the Alliance for Health Policy and Systems Research Chief delegate of the Norwegian delegation on the Intergovernmental Working Group on Public

Health, Innovation and Intellectual Property, WHO Participant in meeting on Collaborative arrangements for global health research May 11 2009 Supervising PhD student on Open source drug discovery as a mechanism for innovation of drugs for

neglected diseases

EUR/RC60/7 Rev.1 Add.3 page 14 NORWAY – Røttingen cont’d


Frønsdal KB, Facey K, Klemp M, Norderhaug IN, Merland B, Røttingen JA Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoringprocesses. International Journal of Technology Assessment in Health Care. 2010; 26:309-16.

Velasco Garrido M, Gerhardus A, Røttingen JA, Busse R. Developing Health Technology Assessment to address health care system needs. Health Policy. 2010; 94:196-202. Epub 2009 3 Nov.

Røttingen JA, Buss PM, Davies S, Toure O. Global health- research architecture: time for mergers? Lancet 2009; 373: 193-5.

Guerin PJ, Næss LM, Fogg C, Rosenqvist E, Pinoges L, Bajunirwe F, Nabasumba C, Borrow R,Frøholm Lo, Ghabri SG, Batwala V, Twesigye R, Aaberge IS, Røttingen JA, Piola P, Caugant DA Immunogenicity of Fractional Doses of Tetravalent A/C/Y!W135 Meningococcal PolysaccharideVaccine: results from a randomised non-inferiority controlled trial in Uganda. Public Library of Science Neglected Tropical Diseases. 2008; 2: e342.

Olliaro PJ, Guerin Pl, Gerstl S, Haaskjold AA, Røttingen JA, Sundar S. Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004. Lancet InfectiousDiseases 2005; 5: 763-74.



CURRICULUM VITAE Member State making nomination: PORTUGAL

Family name CARVALHO-OLIVEIRA First/Other names Isabel Male/Female Female Date of birth 27 February 1978



Research management; proteomies


PhD in Biology (Molecular Biology) from the Faculty of Science, University of Lisbon, summa cum laude

2008


Coordinator of the Research Management Office at the Nacional de Saude Instituto Dr Ricardo Jorge

Jan 2009–present

PhD student at Erasmus University, The Netherlands and the Nacional de Saude Instituto Dr Ricardo Jorge


Involved in the coordination of the Portuguese Roadmap for Health Research Establishment of the Research Management Office at Instituto Nacional de Saude Dr Ricardo Jorge, which provides for research and development projects financial follow-up designs strategies for monitoring, evaluates such projects and provides subsequent financial support.


Carvalho-Oliveira IM, Charro N, Aarbiou J, Buijs-Offerman RM, Wilke M, Schettgen T, Kraus T, Titulaer MK, Burgers P, Luider TM, Penque D, Scholte BJ (2009), "Proteomic analysis ofnaphthalene-induced airway epithelial injury and repair in a cystic fibrosis mouse model" Journal of Proteome Research, Jul;8(7):3606-16.

Oleastro M, Cordeiro R, Ferrand J, Nunes E, Lehours P, Carvalho-Oliveira I, Mendes AI, Penque D, Monteiro L, Mégraud F, Ménard A (2008), "Evaluation of the clinical significance of homB, a novel candidate marker of Helicobacter pylori strains associated with peptic ulcer disease." Journal of Infectious Diseases, Nov 1;198(9):1379-87.

Carvalho-Olivcira I, Scholte BJ, Penque D. (2007), "What have we learned from mouse models forcystic fibrosis?", Expert Review of Molecular Diagnostics, Jul;7(4):407-17. Review.

Harris CM, Mendes F, Dragomir A, Doull JJ, Carvalho-Olivcira I, Bebok Z, Clancy JP, Eubanks V, Sorscher EJ, Roomans GM, Amaral MD, McPherson MA, Penque D, Dormer RI. (2004),"Assessment of CFTR localisation in native airway epithelial cells obtained by nasal brushing", Journal of Cystic Fibrosis., Aug;3 SuppI 2:43-8. Review.

Carvalho-Oliveira I, Efthyrniadou A, Malhó R, Nogueira P, Tzetis M, Kanavakis E, Amaral MD, PenqueD. "CFTR localization in native airway cells and cell lines expressing wild-type or F508del-CFTR by a panel of different antibodies.", Journal of Histochemistry and Cytochemistry. 2004 Feb;52(2):193-203



CURRICULUM VITAE Member State making nomination: REPUBLIC OF MOLDOVA

Family name GROSSU First/Other names Aurel Male/Female Male Date of birth 6 February 1949


ul. Lapushneanu 4/1 2004 Chisinau, Moldova Tel: 003732 256102; Fax: 00372 723620; mobile: (0) 799 56957 E-mail: [email protected]


Cardiology


Postgraduate studies at the All-Union Cardiology Research Centre, Moscow 1981–1984Qualification in cardiology, St. Petersburg, Russian Federation 1979Graduate of the State Medical Institute, Chisinau 1972


Deputy Director for Research, Institute of Cardiology 1998 to presentSuccessively (Researcher, Senior Researcher, Director) Urgent Cardiology Clinic 1984–1998Chairman of the Ministry of Health Council of Experts Chairman of the Ministry of Health Commission on Cardiology and Rheumatology



Aritmiile cardiace. Diagnosticare si tratament Monografie, Chisinau, 1999, Firma Editorial Poligrafica, “Tipografia Centrala” (in Romanian)

Long-term prognosis in diabetic patients with acute coronary syndrome, Journal of Coronary ArteryDisease, Istanbul, Turkey, 2005

Metabolic Treatment with L-Carnitine in Acute Anterior ST Segment Elevation Myocardial Infarction. A Randomized Controlled Trial, CEDIM 2 Study Organization. Cardiology 2006; 106:215–223. With G. Tarantinia, D. Scrutiniob, P. Bruzzic, L. Bonic, P. Rizzond, Sabino Ilicetoa

Clinical and paraclinical characteristics of patients with ischemic stroke and atrial fibrillation. International Journal of Stroke vol. 3, supplement 1, 2008, PO 01–30, Abstracts of the 6th World Stroke Congress and Xth International Sympozium of Thrombolysis and Acute Stroke Therapy

Sincopa, diagnosicare si tratament. Monografie. Editura Universul, Chisinau, 2009 (in Romanian)



CURRICULUM VITAE Member State making nomination: SPAIN

Family name ANTÓ BOQUÉ First/Other names Josep M. Male/Female Male Date of birth 17 August 1952


CENTRO de Investigacion en Epidemjologia Ambiental (CREAL) Parc de Recerca Biomedica de Barcelona (Despatx 195) Doctor Aiguader 88, 08003 Barcelona Tel. +34932147360; mobile: 6499270241; Fax +34 932147302; e-mail: [email protected] www.creal.cat


Epidemiology and public health. Epidemiology of asthma and chronic obstructive pulmonary disease


Doctor of medicine and surgery, Autonomous University of Barcelona 1990Specialist in internal medicine, Autonomous University of Barcelona 1981Specialist in respiratory medicine, Autonomous University of Barcelona 1981Graduated in medicine and surgery, Autonomous University of Barcelona 1975


Director, Centre for Research in Environmental Epidemiology (CREAL) Dec 2005 to presentProfessor of Medicine, Department of Experimental Sciences and Health,

Pompeu Fabra University. Apr 2001 to present

Director, Centre Network for Biomedical Research and Public health 2007-2010Director, Municipal Institute of Medical Research 2005-2006Vice-Chancellor for Science Policy, Pompeu Fabra University 2001-2003



Kogevinas M, Antó, JM, Sunyer J, Tobias A, Kromhout H, Burney P, and the European Community Respiratory Health Survey Study Group. Occupational asthma in Europe and other industrialisedareas: a population-based study. Lancet 1999; 353: 1750-1754

Kogevinas M, Zock JP, Jarvis D, Kromhout H, Lillienberg L, Plana E, Radon K, Toren K, Alliksoo A,Benke G, Blanc PD, Dahlman-Hoglund A, D'Errico A, Hery M, Kennedy S, Kunzli N, Leynaert B, Mirabelli MC, Muniozguren N, Norback 0, Olivieri M, Payo F, Villani S, van Sprundel M, Urrutia I,Wieslander G, Sunyer J, Antó JM. Exposure to substances in the workplace and new-onset asthma: an international prospective population-based study (ECRHS-II). Lancet 2007; 370; 336–341

Delelos Gl, Gimeno 0, Arif M, Burau KD, Carson A, Lusk C, Stock T, Symanski E, Whitehead LW, Zock JP, Benavides FG, Antó JM. Occupational risk factors and asthma among health care professionals. American Journal of Respiratory and Critical Care Medicine. 2007 Apr 1;175(7):667–675

EUR/RC60/7 Rev.1 Add.3 page 18 SPAIN – Antó Boqué cont’d Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Antó JM. Regular physical activity modifies

smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: apopulation-based cohort study. American Journal of Respiratory and Critical Care Medicine. 2007 Mar 1;175(5):458–463

Puhan MA, Garda-Aymerich J, Frey M, ter Riet G, Antó JM, Agusti AG, Gomez FP, Rodriguez-Roisin R, Moons KG, Kessels AG, Held U. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009 Aug29;374(9691 ):704–711



CURRICULUM VITAE Member State making nomination: SPAIN

Family name RODRÍGUEZ ARTALEJO First/Other names Fernando Male/Female Male Date of birth


[email protected]


Preventive Medicine and Public Health

Professional education : relevant important qualifications Year

Specialist in Preventive Medicine and Public Health, vfa MIR. La Paz Hospital 1987Doctor of Medicine, Department of Preventive Medicine and Public Health, Autonomous

University of Madrid 1986

Master in Public Health 1985Graduate in medicine, Autonomous University of Madrid 1983


Professor of Preventive Medicine and Public Health. Autonomous University of Madrid

2000 to present

Professor of Preventive Medicine and Public Health. University of the Basque Country

1995–2000

Head of Environmental Risk Assessment Unit, Directorate-General of Public Health

Various posts in Ministry of Health and Consumer Affairs 1987–1991


Supervisor of 25 doctoral dissertations, three of which received Premio Extraordinario del Doctorado Author or co-author of over 100 articles in scientific and professional journals


Royo-Bordonada MA, Gorgojo L, de Oya M, Garcés C, Rodríguez-Artalejo F, Rubio R, del Barrio JL, Martin~Moreno JM. Dietary variety and diversity of Spanish children: Four Provinces Study. [Article in Spanish] Medicina Clinica (Barcelona). 2003 Feb 15;120(5):167-71

Rodríguez-Artalejo F, Guallar E, Borghi C, Dallongeville J, De Backer G, Harcox JP, Hernandez-Veclno R. Jiménez FJ. Massó-Gonzáléz EL, Perk J, Steg PG, Banegas JR; EURIKA Investigators. Rationale arid methods of the European study on Cardiovascular Risk Prevention and Managementin Dally Practice (EURlKA). BMC Public Health. 2010 Jun 30;10:382

Oliveira A, Lopes C, Rodríguez-Artalejo F. Adherence to the Southern European Atlantic Diet and occurrence of nonfatal acute myocardial Infarction. American Journal of Clinical Nutrition. 2010 Jul;92(1):211~7. Epub 2010 May 19

Regidor E, Guallar-Castillón P, Gutiérrez-Fisac JL, Banegas JR, Rodríguez-Artalejo F. Socioeconomic variation in the magnitude of the association between self-rated health and mortality. Annals of Epidemiology. 2010 May;20(5):395-400

EUR/RC60/7 Rev.1 Add.3 page 20 SPAIN – Rodríguez Artalejo cont’d Romero-Fernandez MM. Royo-Bordonada MA, Rodriguez-Arialejo F. Compliance with self-regulation

of television food and beverage advertising aimed at children in Spain. Public Health Nutrition. 2010 Jul; 13(7):1013-21. Epub 2009 Nov 16



CURRICULUM VITAE Member State making nomination: SWITZERLAND

Family name HERRLING First/Other names Paul Linus Male/Female Male Date of birth 16 December 1946


Novartis Pharma AG, WSJ-200.204, Postfach, 4002 Basel Tel: 061 324 62 84; Fax: 061 324 21 41; mobile: 079 321 30 09 Email: [email protected]


Research


Doctorate, University of Zurich Post-doctorate studies at Neuropsychiatry Institute, University of California at Los Angeles


Head of Novartis Institutes for Developing World Medical Research at Novartis Pharma AG

Head of Corporate Research at Novartis International AG Head of Global Research at Novartis Pharma AG Head of Preclinical Research Basel Sandoz Pharma AG


Chairman of the Board of Directors of the Novartis Institute for Tropical Diseases Member of the Scientific Advisory Committee of the Drugs for Neglected Diseases Initiative


Herrling PL. Financing R&D for neglected diseases. Nat Rev Drug Discov. 2009 Feb;8(2):91. Pogacić Kramp V, Herrling P. List of drugs in development for neurodegenerative diseases: update

June 2009. Neurodegener Dis. 2009;6(4):165-212. Epub 2009 Aug 8. Herrling P. Patent sense. Nature. 2007 Sep 13;449(7159):174-5. Herrling P. [First success of research. Soon a drug against dengue fever?]. MMW Fortschr Med. 2007

Apr 19;149(16):12. German. Herrling P. Experiments in social responsibility. Nature. 2006 Jan 19;439(7074):267-8.

Terms of reference of the CEWGCompositionNominations

Date post:	21-Oct-2020
Category:	Documents
Upload:	others
View:	0 times
Download:	0 times

Regional Committee for Europe Sixtieth session...Regional Committee for Europe . Sixtieth session ....

Documents